May 15, 2023
Japan’s Otsuka Pharma Gets FDA Approval for Alzheimer’s Agitation Drug
The U.S. Food and Drug Administration approved Otsuka Pharmaceutical’s brexpiprazole to treat agitation in patients with Alzheimer’s on Thursday, making it the first approved drug for the indication, the company said in a statement. The decision comes after an advisory ...
NEXT EPISODE
PREVIOUS EPISODE